HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Hyperfine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.78+0.02 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $77.56M
- P/E (TTM)
- –
- Dividend yield
- –
Hyperfine, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 51.4%
- Operating margin
- -203.3%
- Net margin
- -210.8%
- Return on equity, FY2025
- -79.0%
Financial strength
- Current ratio
- 6.15
- Debt to equity
- 0.36
- Debt to assets
- 21.0%
- Cash to current liabilities
- 451.3%
Valuation
- P/E ratio
- –
- Price to sales
- 4.69
- Price to book
- 2.11
- Dividend yield
- –